• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Shanghai Public Health Clinical Center Uses Wearable Sensors to Combat Spread of Coronavirus in China

by Fred Pennic 01/31/2020 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Shanghai Public Health Clinical Center Uses Wearable Sensors to Combat Spread of Coronavirus in China

– Shanghai Public Health Clinical Center uses VivaLNK continuous temperature wearable sensors to combat the spread of Coronavirus in China.

– While quarantining patients may limit patient-to-patient contact, contact between caregivers and patients can also be avoided with technology.

VivaLNK, a Campbell, CA-based provider of connected healthcare solutions, today announces Shanghai Public Health Clinical Center (SPHCC) is using VivaLNK’s continuous temperature sensor to combat the spread of Coronavirus in China.

Minimizing Spread of Coronavirus & Other Infectious Diseases in China

A key challenge in combating contagious diseases is limiting the spread of the virus within a hospital. Cross infection from patient-to-patient and patient-to-caregiver can be a major problem. While quarantining patients may limit patient-to-patient contact, contact between caregivers and patients can also be avoided with technology.

Modeled after the previous SARS outbreak, SPHCC contains special wards designed to limit cross infection and to provide more efficient treatments. SPHCC is designated as the primary treatment center in Shanghai and confirmed patients from area hospitals are also sent to the SPHCC for quarantine and treatment.

How The VivaLNK’s Wearable Sensor Works

Working with VivaLNK solution partner, Yijing Health, the temperature sensor is applied directly onto the patient and allows for continuous, real-time monitoring of changes in body temperature. The data is then sent electronically from the patient to a remote observation dashboard at the nursing station, providing a view of the patients.

Now, instead of physically checking the patient temperature every few hours with a mercury thermometer, temperatures can be monitored remotely and automatically, thereby limiting patient-to-caregiver contact. 

Future Deployments in China

SPHCC also plans to deploy other VivaLNK sensors to monitor vitals such as heart rate and respiratory rate.  And in addition to SPHCC, the VivaLNK solution has been deployed in four other hospitals in various locations throughout China.

“VivaLNK is proud to help fight infectious diseases such as the Coronavirus,” said Jiang Li, CEO of VivaLNK. “The world will never be rid of diseases, but more effective methods of prevention and treatment can be achieved through technological advances.”

The VivalNK temperature sensor has clearances from the CFDA, FDA, and CE, and is part of VivaLNK’s medical wearable platform which includes sensors to monitor a variety of other vitals and biometrics. Over-the-counter consumer versions of the temperature sensor are also available under the Enfasmart FeverSense and Nurofen FeverSmart brands.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Caregivers, FDA, Heart, Public Health, sensors

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |